Facebook
Twitter
Telegram
Report an ErrorSelecta Biosciences Balance Sheet 2011-2024 | SELB
Annual Balance Sheet Selecta Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-66 M | -94.8 M | -104 M | -113 M | -70.6 M | -16 M | -23.6 M | -46.6 M | -20.5 M | -9.19 M | - | - | - |
Long Term Debt |
8.79 M | 10.1 M | 8.6 M | 24.8 M | - | - | 21 M | 7.98 M | 11.9 M | 4.82 M | - | - | - |
Long Term Debt Current |
2.17 M | 1.61 M | 1.05 M | 908 K | 372 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 56.2 M | 14.8 M | 38.3 M | 20.6 M | 152 M | 101 M | - | - | - |
Total Current Liabilities |
68.2 M | 25.1 M | 72.3 M | 81.5 M | 34.9 M | 35.1 M | 11 M | 13.7 M | - | - | - | - | - |
Total Liabilities |
445 M | 72.1 M | 137 M | 183 M | 91.2 M | 49.9 M | 49.3 M | 34.3 M | 159 M | 110 M | - | - | - |
Deferred Revenue |
2.31 M | 593 K | 53.9 M | 72 M | 1.67 M | 959 K | 787 K | 1.84 M | 1.31 M | 3.02 M | - | - | - |
Retained Earnings |
-615 M | -395 M | -430 M | -405 M | -336 M | -280 M | -217 M | -152 M | -112 M | -83.9 M | - | - | - |
Total Assets |
305 M | 166 M | 160 M | 165 M | 99.6 M | 44.5 M | 101 M | 89.3 M | 42.8 M | 22.2 M | - | - | - |
Cash and Cash Equivalents |
76.9 M | 106 M | 114 M | 139 M | 89.9 M | 37.4 M | 70.6 M | 58.7 M | 32.3 M | 16.6 M | - | - | - |
Book Value |
-140 M | 93.8 M | 22.5 M | -18 M | 8.4 M | -5.42 M | 51.8 M | 55 M | -116 M | -87.8 M | - | - | - |
Total Shareholders Equity |
-440 M | 93.8 M | 22.5 M | -18 M | 8.4 M | -5.42 M | 51.8 M | 55 M | -116 M | -87.8 M | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Selecta Biosciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
8.23 M | 8.79 M | 8.69 M | 9.16 M | 9.62 M | 10.1 M | 10.5 M | 8.02 M | 8.32 M | 8.6 M | 8.87 M | 9.14 M | 9.4 M | 9.65 M | 9.65 M | 9.65 M | 9.65 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
442 M | 445 M | 45.7 M | 74.1 M | 81.1 M | 72.1 M | 93.4 M | 98.5 M | 89.9 M | 137 M | 186 M | 185 M | 196 M | 183 M | 183 M | 183 M | 183 M | 91.2 M | 91.2 M | 91.2 M | 91.2 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 49.3 M | 49.3 M | 49.3 M | 49.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 21.8 M | 21.8 M | 21.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
412 K | 2.31 M | 4.14 M | 4.23 M | 4.23 M | 593 K | 3.82 M | 16 M | 28 M | 53.9 M | 62.3 M | 75 M | 75.8 M | 72 M | 72 M | 72 M | 72 M | 1.67 M | 1.67 M | 1.67 M | 1.67 M | 959 K | 959 K | 959 K | 959 K | 787 K | 3.26 M | 2.57 M | 1.95 M | 1.84 M | 1.84 M | 1.84 M | 1.84 M | 1.31 M | 1.31 M | 1.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-671 M | -615 M | -437 M | -428 M | -417 M | -395 M | -401 M | -393 M | -402 M | -430 M | -443 M | -425 M | -429 M | -405 M | -405 M | -405 M | -405 M | -336 M | -336 M | -336 M | -336 M | -280 M | -280 M | -280 M | -280 M | -217 M | -217 M | -217 M | -217 M | -152 M | -152 M | -152 M | -152 M | -112 M | -112 M | -112 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
325 M | 305 M | 106 M | 140 M | 156 M | 166 M | 178 M | 188 M | 146 M | 160 M | 167 M | 181 M | 177 M | 165 M | 165 M | 165 M | 165 M | 99.6 M | 99.6 M | 99.6 M | 99.6 M | 44.5 M | 44.5 M | 44.5 M | 44.5 M | 101 M | 101 M | 101 M | 101 M | 89.3 M | 89.3 M | 89.3 M | 89.3 M | 42.8 M | 42.8 M | 42.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
103 M | 76.9 M | 79.6 M | 112 M | 126 M | 106 M | 113 M | 138 M | 113 M | 114 M | 115 M | 126 M | 125 M | 140 M | 139 M | 139 M | 139 M | 89.9 M | 89.9 M | 89.9 M | 89.9 M | 37.4 M | 50.5 M | 60.2 M | 58.2 M | 70.6 M | 72.2 M | 82.6 M | 26.6 M | 58.7 M | 58.7 M | 58.7 M | 58.7 M | 32.3 M | 32.3 M | 32.3 M | - | 16.6 M | - | - | - | 8.06 M | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
-117 M | -140 M | 60.3 M | 65.4 M | 74.6 M | 93.8 M | 84.9 M | 89.6 M | 55.8 M | 22.5 M | -18.7 M | -4.22 M | -19.6 M | -18 M | -18 M | -18 M | -18 M | 8.4 M | 8.4 M | 8.4 M | 8.4 M | -5.42 M | -5.42 M | -5.42 M | -5.42 M | 51.8 M | 51.8 M | 51.8 M | 51.8 M | 55 M | 55 M | 55 M | 55 M | 21 M | 21 M | 21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-117 M | -440 M | 60.3 M | 65.4 M | 74.6 M | 93.8 M | 84.9 M | 89.6 M | 55.8 M | 22.5 M | -18.7 M | -4.22 M | -19.6 M | -18 M | -18 M | -18 M | -18 M | 8.4 M | 8.4 M | 8.4 M | 8.4 M | -5.42 M | -5.42 M | -5.42 M | -5.42 M | 51.8 M | 51.8 M | 51.8 M | 51.8 M | 55 M | 55 M | 55 M | 55 M | -116 M | -116 M | -116 M | - | -87.8 M | - | - | - | -69.5 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency